Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Biocryst Pharmaceuticals buy JPMorgan Chase & Co.

Biocryst Pharmaceuticals
Start price
€4.86
20.11.23 / 50%
Target price
€9.15
20.11.24
Performance (%)
44.15%
End price
€7.00
21.11.24
Summary
This prediction ended on 21.11.24 with a price of €7.00. With a performance of 44.15% the BUY prediction by JPMorgan_Chase___Co_ was a big success. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Biocryst Pharmaceuticals -2.919% -2.919% -15.095%
iShares Core DAX® 0.423% 5.706% 4.696%
iShares Nasdaq 100 4.096% 16.639% 38.946%
iShares Nikkei 225® 4.469% 18.343% 50.386%
iShares S&P 500 1.788% 9.644% 26.896%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Biocryst Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 44.15%
Target price 9.153
Change
Ends at 20.11.24

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $10.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat

JPMorgan Chase & Co. 
0
Report Share
20.11.23
In the thread Trading Biocryst Pharmaceuticals
Prediction Buy
Perf. (%) 44.15%
Target price 9.153
Change
Ends at 20.11.24

Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten

JPMorgan Chase & Co. 
0
Report Share
21.11.24

Stopped prediction by JPMorgan_Chase___Co_ for Biocryst Pharmaceuticals

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€9.37
06.05.25
€11.51
06.05.26
-20.41%
07.05.26

JPMorgan Chase & Co. 
06.05.25 50%